Etienne Suc

2.2k total citations
13 papers, 257 citations indexed

About

Etienne Suc is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Etienne Suc has authored 13 papers receiving a total of 257 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Molecular Biology. Recurrent topics in Etienne Suc's work include Colorectal Cancer Treatments and Studies (3 papers), Cancer Treatment and Pharmacology (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). Etienne Suc is often cited by papers focused on Colorectal Cancer Treatments and Studies (3 papers), Cancer Treatment and Pharmacology (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). Etienne Suc collaborates with scholars based in France and Austria. Etienne Suc's co-authors include Christine Chomienne, Françoise Rigal‐Huguet, Philippe Lefèbvre, Hervé Tilly, E Archimbaud, Maud Janvier, Claude Gardin, Alain Delmer, Sylvie Castaigné and P. Armand and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Urology.

In The Last Decade

Etienne Suc

13 papers receiving 250 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Etienne Suc France 7 126 118 65 51 39 13 257
Shinji Mikami Japan 9 108 0.9× 147 1.2× 35 0.5× 32 0.6× 74 1.9× 20 305
Albaha Barqawi United States 5 107 0.8× 167 1.4× 36 0.6× 187 3.7× 8 0.2× 10 351
Stephen Chanock United States 8 135 1.1× 76 0.6× 21 0.3× 53 1.0× 25 0.6× 10 266
Pierre–Olivier Schischmanoff France 5 55 0.4× 45 0.4× 57 0.9× 34 0.7× 6 0.2× 7 237
Shane G. Supple Australia 5 79 0.6× 45 0.4× 66 1.0× 70 1.4× 10 0.3× 6 224
M. Dicato Luxembourg 8 23 0.2× 65 0.6× 71 1.1× 26 0.5× 46 1.2× 20 243
Lakshminarayanan Nandagopal United States 8 57 0.5× 52 0.4× 11 0.2× 99 1.9× 31 0.8× 22 183
D. D. Liu United States 6 109 0.9× 186 1.6× 5 0.1× 172 3.4× 26 0.7× 7 333
P. Flynn United States 6 178 1.4× 82 0.7× 135 2.1× 23 0.5× 3 0.1× 12 320
Weiying Gu China 10 95 0.8× 76 0.6× 58 0.9× 20 0.4× 10 0.3× 35 247

Countries citing papers authored by Etienne Suc

Since Specialization
Citations

This map shows the geographic impact of Etienne Suc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Etienne Suc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Etienne Suc more than expected).

Fields of papers citing papers by Etienne Suc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Etienne Suc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Etienne Suc. The network helps show where Etienne Suc may publish in the future.

Co-authorship network of co-authors of Etienne Suc

This figure shows the co-authorship network connecting the top 25 collaborators of Etienne Suc. A scholar is included among the top collaborators of Etienne Suc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Etienne Suc. Etienne Suc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Ploussard, Guillaume, Benjamin Pradère, Jean‐Baptiste Beauval, et al.. (2020). Survival Outcomes of Patients with Pathologically Proven Positive Lymph Nodes at Time of Radical Cystectomy with or without Neoadjuvant Chemotherapy. Journal of Clinical Medicine. 9(6). 1962–1962. 9 indexed citations
2.
Puszkiel, Alicja, Cécile Arellano, Christelle Vachoux, et al.. (2019). Factors Affecting Tamoxifen Metabolism in Patients With Breast Cancer: Preliminary Results of the French PHACS Study. Clinical Pharmacology & Therapeutics. 106(3). 585–595. 17 indexed citations
3.
4.
Aparicio, Thomas, François Ghiringhelli, Valérie Boige, et al.. (2018). Bevacizumab Maintenance Versus No Maintenance During Chemotherapy-Free Intervals in Metastatic Colorectal Cancer: A Randomized Phase III Trial (PRODIGE 9). Journal of Clinical Oncology. 36(7). 674–681. 59 indexed citations
5.
Aparicio, Thomas, Jaafar Bennouna, Karine Le Malicot, et al.. (2016). Final results of PRODIGE 9, a randomized phase III comparing no treatment to bevacizumab maintenance during chemotherapy-free intervals in metastatic colorectal cancer.. Journal of Clinical Oncology. 34(15_suppl). 3531–3531. 7 indexed citations
6.
Obéric, Lucie, Benjamin Hébraud, Christian Récher, et al.. (2014). Clinical activity of a new regimen combining gemcitabine and alemtuzumab in high‐risk relapsed/refractory chronic lymphocytic leukemia patients. European Journal Of Haematology. 94(1). 37–42. 6 indexed citations
7.
Caty, Armelle, Stéphane Oudard, Yves Humblet, et al.. (1997). Phase II study of vlnorelbine in patients with hormone refractory prostate cancer. European Journal of Cancer. 33. S33–S33. 5 indexed citations
8.
Merrouche, Yacine, Jean Marc Extra, D Abigerges, et al.. (1997). High dose-intensity of irinotecan administered every 3 weeks in advanced cancer patients: a feasibility study.. Journal of Clinical Oncology. 15(3). 1080–1086. 48 indexed citations
9.
Suc, Etienne, et al.. (1996). [Cell lysis syndrome after chemotherapy for cancer of the bladder].. PubMed. 25(40). 2044–2044. 2 indexed citations
10.
Castaigné, Sylvie, Philippe Lefèbvre, Christine Chomienne, et al.. (1993). Effectiveness and pharmacokinetics of low-dose all-trans retinoic acid (25 mg/m2) in acute promyelocytic leukemia. Blood. 82(12). 3560–3563. 4 indexed citations
11.
Castaigné, Sylvie, Philippe Lefèbvre, Christine Chomienne, et al.. (1993). Effectiveness and pharmacokinetics of low-dose all-trans retinoic acid (25 mg/m2) in acute promyelocytic leukemia. Blood. 82(12). 3560–3563. 73 indexed citations
12.
Suc, Etienne, A Robert, H Rubie, et al.. (1989). Immunohistochemical Detection of Post-Therapy Residual Testicular Lymphoblasts in Childhood Acute Lymphoblastic Leukemia (All). Pediatric Hematology and Oncology. 6(2). 121–135. 6 indexed citations
13.
Roché, H., et al.. (1989). Stage IE Nonhodgkin’s Lymphoma of the Testis: A Need for a Brief Aggressive Chemotherapy. The Journal of Urology. 141(3 Part 1). 554–556. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shinji Mikami Breakdown of academic impact, for papers by Albaha Barqawi Breakdown of academic impact, for papers by Stephen Chanock Breakdown of academic impact, for papers by Pierre–Olivier Schischmanoff Breakdown of academic impact, for papers by Shane G. Supple Breakdown of academic impact, for papers by M. Dicato Breakdown of academic impact, for papers by Lakshminarayanan Nandagopal Breakdown of academic impact, for papers by D. D. Liu Breakdown of academic impact, for papers by P. Flynn Breakdown of academic impact, for papers by Weiying Gu
Rankless by CCL
2026